Introduction: Treatment of unresectable liver metastases (LM) from uveal melanoma (UM) remains a major clinical challenge. Systemic chemotherapy and chemoimmunotherapy regimens extrapolated from cutaneous melanoma are considered to be ineffective in therapy of metastases from uveal melanoma. Studies suggest that the progression of hepatic metastases rather than the primary tumor or metastases in other organs determines survival.
View Article and Find Full Text PDFTargeted therapy of non-small cell lung cancer (NSCLC) patients with mutations in the epidermal growth factor receptor () gene has been associated with improved prognosis. However, there is a shortage on data from real-world clinical practice in management of -positive NSCLC patients in Poland. The present study retrospectively analyzed data from the INSIGHT study to evaluate the incidence and clinical management of EGFR-positive NSCLC in Poland.
View Article and Find Full Text PDF